MILLIIN Medical
Pioneering Smart Dialysis Product and Service Innovation in China

Beijing Milliin Medical Technology Development Co., Ltd. (abbreviated as “ Milliin Medical ”), founded in 2004, is one of the earliest pioneers in China‘s hemodialysis field. As a national high-tech enterprise, Milliin Medical integrates blood purification equipment, disposable blood purification consumables, and hemodialysis centers into a comprehensive solution provider. After nearly two decades of development, the company’s core products and services now span the entire hemodialysis product line.
Currently, Milliin’s products are distributed across 29 provinces, municipalities, and autonomous regions in China, serving nearly 1,000 hospital clients. The cumulative installed base of its equipment ranks among the highest nationwide, with a consistent market share exceeding 50% in Beijing. Both product quality and after-sales services have received widespread acclaim across the industry.

Leading the Industry into the Intelligent Era

As a National High-Tech Enterprise, Milliin Medical has consistently led the forefront of technological innovation in the industry. Leveraging its extensive industrial ecosystem, Milliin Medical integrates cutting-edge technologies such as artificial intelligence (AI), big data, and the Internet of Things (IoT) to collect and analyze massive dialysis-related data, developing data-driven intelligent applications that have gained clinical recognition.
Key Milestones
2024: The Milliin MIX Series Hemodialysis Equipment officially received market approval, marking a milestone in China’s independently developed, safe, stable, and high-performance dialysis systems.
2023: Milliin’s full water treatment product line pioneered the 2.0 era of whole-machine high-frequency disinfection and was selected for the Medical Equipment Product Collection for County-Level General Hospitals by the China Association of Medical Equipment.
2022: Ten models of Milliin’s self-developed hemodialysis water treatment systems (thermal and chemical disinfection types) were recognized in the 8th Batch of Excellent Domestic Medical Devices program initiated by the National Health Commission.
2021: The Milliin S9 Whole-Machine Thermal Disinfection Water Treatment System, equipped with an IoT management platform, propelled China’s hemodialysis water treatment into the intelligent era.
2015: The Milliin S7 Whole-Machine Thermal Disinfection Water Treatment System debuted as China’s first such system, sparking nationwide adoption of high-frequency disinfection standards.
2008: Milliin launched China’s first membrane thermal disinfection water treatment system in collaboration with the Chinese Academy of Sciences, ushering in the era of high-frequency thermal disinfection for water treatment equipment.

Comprehensive Strategic Deployment
Across the Hemodialysis Value Chain
While advancing the R&D and production of blood purification equipment, Milliin Medical has also established Shenghe Medical and Sewei Medical, forming a comprehensive system integrating "nephrology diagnosis & treatment + equipment R&D + dialysis services". By operating hospitals and engaging deeply in frontline clinical practice, Milliin grounds its work in real-world clinical needs, combining practical application scenarios with product development. This fusion of theory and practice enables clinical insights to drive equipment innovation, delivering products that better meet clinical demands. This creates a virtuous cycle where clinical needs and technological advancements mutually reinforce each other.
Quality lighting up life
To lead innovation in smart dialysis products and services in China, Milliin Medical relentlessly pursues excellence, guided by its philosophy of "Quality Illuminates Life." Over two decades, the company has dedicated itself to extending patient survival and enhancing the quality of life for dialysis patients through premium products and superior services, bringing hope to countless patients and families. Milliin continues to contribute to the realization of "Healthy China 2030" by advancing healthcare accessibility and outcomes.